Literature DB >> 4834899

Postsympathectomy neuralgia. Amelioration with diphenylhydantoin and carbamazepine.

N H Raskin, S Levinson, P M Hoffman, J B Pickett, H L Fields.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4834899     DOI： 10.1016/0002-9610(74)90238-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  14 in total

Review 1.  Causalgia, pathological pain, and adrenergic receptors.

Authors:  E R Perl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  What lies above and beyond the concept of "sympathetically maintained pain"?

Authors:  M Elam
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

3.  Indications, technique, and results in 336 tibioperoneal reconstructions.

Authors:  F P Gall; F Franke; D Raithel
Journal:  Cardiovasc Dis       Date:  1980-09

4.  [Treatment of palmar and axillary hyperhidrosis: thoracoscopic resection of the sympathetic chain].

Authors:  R Rieger; S Pedevilla; S Pöchlauer
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

5.  [Not Available].

Authors:  W Jänig
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

6.  Retroperitoneoscopic lumbar sympathectomy for the treatment of plantar hyperhidrosis: technique and preliminary findings.

Authors:  R Rieger; S Pedevilla
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

7.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 8.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

9.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

10.  [Anticonvulsant agents in neuralgic pain.].

Authors:  I Jurna; M Zenz
Journal:  Schmerz       Date:  1992-06       Impact factor: 1.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.